Skip to main content
Top
Published in: Infectious Agents and Cancer 1/2024

Open Access 01-12-2024 | Cervical Cancer | Research

Feasibility and applicability of self-sampling based online cervical cancer screening: findings from the China online cervical cancer screening trial

Authors: Yi Zhang, Hui Du, Chun Wang, Xia Huang, Xinfeng Qu, Ruifang Wu

Published in: Infectious Agents and Cancer | Issue 1/2024

Login to get access

Abstract

Objective

This study aims to evaluate the feasibility and applicability of an online cervical cancer screening program using a website as the public platform and self-collected HPV testing as the primary screening method.

Methods

A website (mcareu.com) was developed to facilitate the online cervical cancer screening program by Peking University Shenzhen Hospital (PUSH). Women in Shenzhen could register for participation on the website by providing essential demographic data. Sampling kits and specimens were delivered through regular logistics. Eligible women collected vaginal samples by themselves using the provided kits and in referring of the graphic guidance. The specimens were tested for HPV at PUSH or a reference lab, and the results were accessible on the website through participants' personal accounts. Participants who tested positive for high-risk HPV were scheduled for colposcopy and biopsies. The demographic and social background data of the eligible participants were analyzed to evaluate the feasibility and applicability of the online screening approach.

Results

A total of 1712 applicants registered for participation, with 99.9% (1710/1712) completing registration with full data. The analysis included 1560 applicants aged 30–59, with an average age of 41.1 (± 7.6) years. Among them, 83.3% (1299/1560) provided self-collected samples for testing. Age-group analysis revealed an overall sample provision rate (SPR) exceeded 80% in all age groups. A significant difference in SPR was observed only between the 30–34 and 45–49 age groups (p < 0.05), while no significant differences were found among other age groups. 99.7% of the samples were tested qualified, and there was no significant difference in sampling failure rate among age groups. Analysis of demographic and social elements showed no significant impact on the rates of sample provision among groups in most of the social elements but the medical insurance and the monthly family-incomes.

Conclusion

The findings demonstrate that online cervical cancer screening is reliable for self-registration, self-sampling, and self-ordering for specimen transportation. It is suitable for women of all ages needing to be screened, irrespective of social elements, and effectively facilitates screening for women with limited access to medical resources. Therefore, online screening holds promise as an effective approach to increase screening coverage.
Literature
1.
go back to reference Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–49.CrossRefPubMed Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–49.CrossRefPubMed
2.
go back to reference Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370:890–907.CrossRefPubMed Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370:890–907.CrossRefPubMed
3.
4.
go back to reference Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO.
5.
go back to reference Fanghui XCQYZYZ. WHO′s global strategy of cervical cancer elimination and the challenges and initiatives in China. Natl Med J China. 2020;100:3484–8. Fanghui XCQYZYZ. WHO′s global strategy of cervical cancer elimination and the challenges and initiatives in China. Natl Med J China. 2020;100:3484–8.
7.
go back to reference Ronco G, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014;383:524–32.CrossRefPubMed Ronco G, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014;383:524–32.CrossRefPubMed
8.
go back to reference Belinson JL, et al. Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing. Int J Cancer. 2012;130:1855–60.CrossRefPubMed Belinson JL, et al. Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing. Int J Cancer. 2012;130:1855–60.CrossRefPubMed
9.
10.
go back to reference Belinson JL, et al. The development and evaluation of a community based model for cervical cancer screening based on self-sampling. Gynecol Oncol. 2014;132:636–42.CrossRefPubMed Belinson JL, et al. The development and evaluation of a community based model for cervical cancer screening based on self-sampling. Gynecol Oncol. 2014;132:636–42.CrossRefPubMed
11.
go back to reference Logan L, McIlfatrick S. Exploring women’s knowledge, experiences and perceptions of cervical cancer screening in an area of social deprivation. Eur J Cancer Care (Engl). 2011;20:720–7.CrossRefPubMed Logan L, McIlfatrick S. Exploring women’s knowledge, experiences and perceptions of cervical cancer screening in an area of social deprivation. Eur J Cancer Care (Engl). 2011;20:720–7.CrossRefPubMed
12.
go back to reference Wu R, Qu X, Du H, Liu Z, Hu Q, Wang C, Zhang L, Zhao J, Wang G, Belinson J. A pilot study to evaluate an internet-based cervical cancer screening model based on self-sampling. Health. 2016;8:672–9.CrossRef Wu R, Qu X, Du H, Liu Z, Hu Q, Wang C, Zhang L, Zhao J, Wang G, Belinson J. A pilot study to evaluate an internet-based cervical cancer screening model based on self-sampling. Health. 2016;8:672–9.CrossRef
13.
go back to reference Fajardo-Bernal L, et al. Home-based versus clinic-based specimen collection in the management of Chlamydia trachomatis and Neisseria gonorrhoeae infections. Cochrane Database Syst Rev. 2015;2015:Cd011317.PubMedPubMedCentral Fajardo-Bernal L, et al. Home-based versus clinic-based specimen collection in the management of Chlamydia trachomatis and Neisseria gonorrhoeae infections. Cochrane Database Syst Rev. 2015;2015:Cd011317.PubMedPubMedCentral
14.
go back to reference Wilson E, et al. Internet-accessed sexually transmitted infection (e-STI) testing and results service: a randomised, single-blind, controlled trial. PLoS Med. 2017;14:e1002479.CrossRefPubMedPubMedCentral Wilson E, et al. Internet-accessed sexually transmitted infection (e-STI) testing and results service: a randomised, single-blind, controlled trial. PLoS Med. 2017;14:e1002479.CrossRefPubMedPubMedCentral
15.
go back to reference Kersaudy-Rahib D, et al. Chlamyweb Study II: a randomised controlled trial (RCT) of an online offer of home-based Chlamydia trachomatis sampling in France. Sex Transm Infect. 2017;93:188–95.CrossRefPubMed Kersaudy-Rahib D, et al. Chlamyweb Study II: a randomised controlled trial (RCT) of an online offer of home-based Chlamydia trachomatis sampling in France. Sex Transm Infect. 2017;93:188–95.CrossRefPubMed
16.
go back to reference Grandahl M, Mohammad J, Larsson M, Herrmann B. Users’ Opinions of Internet-based Self-sampling Tests for Chlamydia trachomatis and Neisseria gonorrhoeae in Sweden. Acta Derm Venereol. 2020;100:adv00315.CrossRefPubMed Grandahl M, Mohammad J, Larsson M, Herrmann B. Users’ Opinions of Internet-based Self-sampling Tests for Chlamydia trachomatis and Neisseria gonorrhoeae in Sweden. Acta Derm Venereol. 2020;100:adv00315.CrossRefPubMed
17.
go back to reference Lee HY, Koopmeiners JS, Rhee TG, Raveis VH, Ahluwalia JS. Mobile phone text messaging intervention for cervical cancer screening: changes in knowledge and behavior pre-post intervention. J Med Internet Res. 2014;16:e196.CrossRefPubMedPubMedCentral Lee HY, Koopmeiners JS, Rhee TG, Raveis VH, Ahluwalia JS. Mobile phone text messaging intervention for cervical cancer screening: changes in knowledge and behavior pre-post intervention. J Med Internet Res. 2014;16:e196.CrossRefPubMedPubMedCentral
18.
go back to reference Nelson EJ, et al. Human Papillomavirus infection in women who submit self-collected vaginal swabs after internet recruitment. J Community Health. 2015;40:379–86.CrossRefPubMed Nelson EJ, et al. Human Papillomavirus infection in women who submit self-collected vaginal swabs after internet recruitment. J Community Health. 2015;40:379–86.CrossRefPubMed
19.
go back to reference Stoler MH, et al. High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study. Am J Clin Pathol. 2011;135:468–75.CrossRefPubMed Stoler MH, et al. High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study. Am J Clin Pathol. 2011;135:468–75.CrossRefPubMed
20.
go back to reference Belinson JL, Pretorius RG. A standard protocol for the Colposcopy Exam. J Low Genit Tract Dis. 2016;20:e61-62.CrossRefPubMed Belinson JL, Pretorius RG. A standard protocol for the Colposcopy Exam. J Low Genit Tract Dis. 2016;20:e61-62.CrossRefPubMed
21.
go back to reference Reich O, et al. Precancerous lesions of the cervix, vulva and vagina according to the 2014 WHO classification of tumors of the female genital tract. Geburtshilfe Frauenheilkd. 2015;75:1018–20.CrossRefPubMedPubMedCentral Reich O, et al. Precancerous lesions of the cervix, vulva and vagina according to the 2014 WHO classification of tumors of the female genital tract. Geburtshilfe Frauenheilkd. 2015;75:1018–20.CrossRefPubMedPubMedCentral
22.
go back to reference Verdoodt F, et al. Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials. Eur J Cancer. 2015;51:2375–85.CrossRefPubMed Verdoodt F, et al. Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials. Eur J Cancer. 2015;51:2375–85.CrossRefPubMed
23.
go back to reference Kuhn L, et al. Clinical evaluation of modifications to a human papillomavirus assay to optimise its utility for cervical cancer screening in low-resource settings: a diagnostic accuracy study. Lancet Glob Health. 2020;8:e296–304.CrossRefPubMedPubMedCentral Kuhn L, et al. Clinical evaluation of modifications to a human papillomavirus assay to optimise its utility for cervical cancer screening in low-resource settings: a diagnostic accuracy study. Lancet Glob Health. 2020;8:e296–304.CrossRefPubMedPubMedCentral
24.
go back to reference Wong EL, Cheung AW, Wong AY, Chan PK. Acceptability and feasibility of HPV self-sampling as an alternative primary cervical cancer screening in under-screened population groups: a cross-sectional study. Int J Environ Res Public Health. 2020;17 Wong EL, Cheung AW, Wong AY, Chan PK. Acceptability and feasibility of HPV self-sampling as an alternative primary cervical cancer screening in under-screened population groups: a cross-sectional study. Int J Environ Res Public Health. 2020;17
25.
go back to reference Montealegre JR, Mullen PD, Jibaja-Weiss ML, Vargas Mendez MM, Scheurer ME. Feasibility of cervical cancer screening utilizing self-sample human papillomavirus testing among Mexican immigrant women in Harris County, Texas: a pilot study. J Immigr Minor Health. 2015;17:704–12.CrossRefPubMed Montealegre JR, Mullen PD, Jibaja-Weiss ML, Vargas Mendez MM, Scheurer ME. Feasibility of cervical cancer screening utilizing self-sample human papillomavirus testing among Mexican immigrant women in Harris County, Texas: a pilot study. J Immigr Minor Health. 2015;17:704–12.CrossRefPubMed
26.
go back to reference Zehbe I, et al. Feasibility of self-sampling and human papillomavirus testing for cervical cancer screening in First Nation women from Northwest Ontario, Canada: a pilot study. BMJ Open. 2011;1:e000030.CrossRefPubMedPubMedCentral Zehbe I, et al. Feasibility of self-sampling and human papillomavirus testing for cervical cancer screening in First Nation women from Northwest Ontario, Canada: a pilot study. BMJ Open. 2011;1:e000030.CrossRefPubMedPubMedCentral
27.
go back to reference Arbyn M, Smith SB, Temin S, Sultana F, Castle P. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. BMJ. 2018;363:k4823.CrossRefPubMedPubMedCentral Arbyn M, Smith SB, Temin S, Sultana F, Castle P. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. BMJ. 2018;363:k4823.CrossRefPubMedPubMedCentral
28.
go back to reference Tiro JA, et al. Understanding patients’ perspectives and information needs following a positive home human papillomavirus self-sampling kit result. J Womens Health (Larchmt). 2019;28:384–92.CrossRefPubMed Tiro JA, et al. Understanding patients’ perspectives and information needs following a positive home human papillomavirus self-sampling kit result. J Womens Health (Larchmt). 2019;28:384–92.CrossRefPubMed
29.
go back to reference Racey CS, et al. Randomized intervention of self-collected sampling for human papillomavirus testing in under-screened rural women: uptake of screening and acceptability. J Womens Health (Larchmt). 2016;25:489–97.CrossRefPubMed Racey CS, et al. Randomized intervention of self-collected sampling for human papillomavirus testing in under-screened rural women: uptake of screening and acceptability. J Womens Health (Larchmt). 2016;25:489–97.CrossRefPubMed
31.
go back to reference Mullins R, Scalzo K, Sultana F. Self-sampling for cervical screening: could it overcome some of the barriers to the Pap test? J Med Screen. 2014;21:201–6.CrossRefPubMed Mullins R, Scalzo K, Sultana F. Self-sampling for cervical screening: could it overcome some of the barriers to the Pap test? J Med Screen. 2014;21:201–6.CrossRefPubMed
32.
go back to reference Tobin K, et al. Acceptability and feasibility of a Peer Mentor program to train young Black men who have sex with men to promote HIV and STI home-testing to their social network members. AIDS Care. 2018;30:896–902.CrossRefPubMedPubMedCentral Tobin K, et al. Acceptability and feasibility of a Peer Mentor program to train young Black men who have sex with men to promote HIV and STI home-testing to their social network members. AIDS Care. 2018;30:896–902.CrossRefPubMedPubMedCentral
33.
go back to reference Tranberg M, et al. Good concordance of HPV detection between cervico-vaginal self-samples and general practitioner-collected samples using the Cobas 4800 HPV DNA test. BMC Infect Dis. 2018;18:348.CrossRefPubMedPubMedCentral Tranberg M, et al. Good concordance of HPV detection between cervico-vaginal self-samples and general practitioner-collected samples using the Cobas 4800 HPV DNA test. BMC Infect Dis. 2018;18:348.CrossRefPubMedPubMedCentral
34.
go back to reference Du H, et al. Evaluation of Cobas HPV and SeqHPV assays in the Chinese Multicenter Screening Trial. J Low Genit Tract Dis. 2021;25:22–6.CrossRefPubMed Du H, et al. Evaluation of Cobas HPV and SeqHPV assays in the Chinese Multicenter Screening Trial. J Low Genit Tract Dis. 2021;25:22–6.CrossRefPubMed
Metadata
Title
Feasibility and applicability of self-sampling based online cervical cancer screening: findings from the China online cervical cancer screening trial
Authors
Yi Zhang
Hui Du
Chun Wang
Xia Huang
Xinfeng Qu
Ruifang Wu
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Infectious Agents and Cancer / Issue 1/2024
Electronic ISSN: 1750-9378
DOI
https://doi.org/10.1186/s13027-024-00583-6

Other articles of this Issue 1/2024

Infectious Agents and Cancer 1/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine